Assessment of Patient Satisfaction Program "Gestational Diabetes"
NCT ID: NCT02945540
Last Updated: 2016-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
350 participants
OBSERVATIONAL
2016-04-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study must include all patients participating in the therapeutic education program for a year and meeting the inclusion criteria.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational diabetes diagnosis based on OGTT glucose 75g, performed after 24 weeks of gestation
* Women aged 18 and over
* After 24th week of gestation
* Before 36th week of gestation
* initial management in therapeutic education at the University Hospital of Caen
Exclusion Criteria
* women under 18 years
* Initial management of gestational diabetes by health professionals outside the University Hospital of Caen
* Poor understanding of the French language
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Caen University Hospital
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lidwine TRONCY, MSc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-198
Identifier Type: -
Identifier Source: org_study_id